Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen-Induced Lung Cancer and Determines the Efficacy of Immunotherapy Article

Liu, Chia-Hsin, Chen, Zhong, Chen, Kong et al. (2021). Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen-Induced Lung Cancer and Determines the Efficacy of Immunotherapy . CANCER RESEARCH, 81(1), 144-157. 10.1158/0008-5472.CAN-20-1994

cited authors

  • Liu, Chia-Hsin; Chen, Zhong; Chen, Kong; Liao, Fu-Tien; Chung, Chia-En; Liu, Xiaoping; Lin, Yu-Chun; Keohavong, Phouthone; Leikauf, George D; Di, Yuanpu Peter

authors

publication date

  • January 1, 2021

published in

keywords

  • 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE
  • GENE-EXPRESSION
  • IFN-GAMMA
  • INHALATION
  • K-RAS MUTATIONS
  • Life Sciences & Biomedicine
  • MECHANISMS
  • Oncology
  • RISK-FACTORS
  • SQUAMOUS-CELL CARCINOMA
  • Science & Technology
  • TUMORIGENESIS
  • TUMORS

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 144

end page

  • 157

volume

  • 81

issue

  • 1